| Searching for prostate cancer stem cells: markers and methods B Sharpe, M Beresford, R Bowen, J Mitchard, AD Chalmers Stem Cell Reviews and Reports 9, 721-730, 2013 | 74 | 2013 |
| Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts BP Sharpe, A Hayden, A Manousopoulou, A Cowie, RC Walker, ... Cell Reports Medicine 3 (6), 2022 | 15 | 2022 |
| A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan‐1 positive stromal cells B Sharpe, DA Alghezi, C Cattermole, M Beresford, R Bowen, J Mitchard, ... The Prostate 77 (13), 1312-1324, 2017 | 15 | 2017 |
| Genomic analysis of response to neoadjuvant chemotherapy in esophageal adenocarcinoma F Izadi, BP Sharpe, SP Breininger, M Secrier, J Gibson, RC Walker, ... Cancers 13 (14), 3394, 2021 | 11 | 2021 |
| Synteny analysis provides a route to design genus specific PCR primers for rapid identification of all Saccharomyces species B Sharpe, M Hulin, J Thorne Wallis, A Wheals FEMS yeast research 14 (3), 517-525, 2014 | 8 | 2014 |
| Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma NJ Smith, I Reddin, P Policelli, S Oh, N Zainal, E Howes, B Jenkins, ... Research Square, 2024 | 3 | 2024 |
| Targetable fibroblast phenotypes and EMT malignant cell states cooperate to promote tumor progression in esophageal adenocarcinoma RC Walker, SP Breininger, BP Sharpe, J Harrington, I Reddin, C Tse, ... | 3 | 2023 |
| Patient-Derived Tumor Organoid and Fibroblast Assembloid Models for interrogation of the tumor microenvironment in Esophageal Adenocarcinoma BP Sharpe, LA Nazlamova, C Tse, DA Johnston, R Blyth, OJ Pickering, ... bioRxiv, 2024.01. 02.572565, 2024 | 1 | 2024 |
| 514 CANCER CELLS PERSIST AFTER COMPLETE PATHOLOGICAL RESPONSE IN ESOPHAGEAL ADENOCARCINOMA R Walker, J Harrington, B Grace, B Sharpe, S Breininger, F Izadi, J Kelly, ... Diseases of the Esophagus 33 (Supplement_1), doaa087. 136, 2020 | 1 | 2020 |
| Modulation of the tumour promoting functions of cancer associated fibroblasts by phosphodiesterase type 5 inhibition increases the efficacy of chemotherapy in human preclinical … A Hayden, A Manousopoulou, A Cowie, R Walker, BP Sharpe, ... bioRxiv, 2020.04. 21.052647, 2020 | 1 | 2020 |
| Prostate cancer stem cells: potential new biomarkers BP Sharpe University of Bath, 2016 | 1 | 2016 |
| Residual cancer cells after apparent complete pathological response to neoadjuvant therapy in oesophageal adenocarcinoma RC Walker, J Harrington, SP Breininger, O Pickering, SL Hill, BP Sharpe, ... British Journal of Surgery 111 (4), znae103, 2024 | | 2024 |
| O086 Genomic analysis of response to neoadjuvant chemotherapy in oesophageal adenocarcinoma SP Breininger, F Izadi, B Sharpe, M Secrier, J Gibson, R Walker, ... British Journal of Surgery 109 (Supplement_4), znac242. 086, 2022 | | 2022 |
| Investigation of Protein Expression Levels of Markers of Non-Response to Neoadjuvant Chemotherapy in Oesophageal Adenocarcinoma on Tissue Microarrays JG Green, BPS Sharpe, ES Shaw JOURNAL OF PATHOLOGY 256, S13-S13, 2022 | | 2022 |
| O-OGC06 Genomic analysis of response to neoadjuvant chemotherapy in oesophageal adenocarcinoma S Breininger, F Izadi, B Sharpe, M Secrier, J Gibson, R Walker, S Rahman, ... British Journal of Surgery 108 (Supplement_9), znab429. 038, 2021 | | 2021 |
| Digital pathology and machine learning for prediction of response to neoadjuvant chemotherapy in oesophageal adenocarcinoma B Sharpe, S Rahman, J Early, G Vigneswaran, J Horne, B Grace, J West, ... The Journal of Pathology 255, S35, 2021 | | 2021 |
| Modulation of the tumour promoting functions of cancer associated fibroblasts by phosphodiesterase type 5 inhibition increases the efficacy of chemotherapy in human preclinical … P Collier, M Rose-Zerilli, BP Sharpe, F Izadi, A Hayden, A Cowie, ... Zenodo, 2021 | | 2021 |
